neoadjuvant therapy for breast cancer

Release time ：Dec-17,2024

Neoadjuvant therapy for breast cancer encompasses treatments such as chemotherapy, radiotherapy, and targeted therapy, with the goals of downsizing tumors, enhancing surgical resection rates, and boosting survival rates. The selection of neoadjuvant therapy is contingent upon the tumor's biological profile, the patient's clinical status, and the therapeutic objectives.

Chemotherapy is the predominant approach within neoadjuvant therapy, employing drugs to eradicate cancer cells and thereby shrinking tumor size. Radiotherapy harnesses radiation to directly target tumor cells, inhibiting their capacity to multiply. Targeted therapy, on the other hand, zeroes in on specific molecular targets within cancer cells, thereby minimizing harm to healthy cells. These therapeutic modalities can be administered in isolation or in concert to optimize treatment outcomes.

Patients receiving neoadjuvant therapy should be closely monitored for treatment response and adverse effects, with regular imaging assessments to track tumor changes. It is imperative that patients adhere to a standardized treatment regimen under medical supervision, refraining from altering medication protocols or discontinuing treatment without guidance. Maintaining a positive mindset and a healthy lifestyle during treatment is also instrumental in facilitating recovery. Should any concerns or discomforts arise, prompt medical consultation is advised.